Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-11-07Clinical Trial Update: Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
This clinical trial update describes a study using chromatic pupillometry to assess the melanopsin-light pathway in Progressive Supranuclear…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) [Phase 2, Phase 3]
Clinical trial update reporting safety and efficacy findings for extended-release amantadine in levodopa-induced dyskinesia in Parkinson's d…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus [Phase 4]
A Phase 4 clinical trial assessed how dexmedetomidine affects activity in the subthalamic nucleus for patients with Parkinson's disease unde…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
This completed exploratory trial investigates using nanotechnology to detect biomarkers of Parkinson's disease from exhaled breath. The stud…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Tremor Monitoring Device
This document reports a completed clinical trial evaluating a tremor monitoring device for patients with Parkinson's disease and essential t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-10-30FDA Approved: RASAGILINE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' original application for rasagiline as a generic treatment for Parkinson disease.
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: Non Motors Aspects in De Novo Parkinson's Disease [Phase 3]
Phase 3 clinical trial update examining non-motor aspects, including apathy, in de novo Parkinson disease.
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: Development and Evaluation of a Guide to Help People With Parkinson's and Their Caregivers to Self-manage Falling [NA]
A clinical trial update describing the development and evaluation of a caregiver guide to help people with Parkinson's disease self-manage f…
-
FDA approval · 2017-10-20FDA Approved: CARBIDOPA — Original Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' Original Application for carbidopa, confirming a generic carbidopa product is approvable. Carbidopa is u…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Impact of Myotensives Techniques, With and Without Auto-reeducation, on the Vital Capacity Forced by the Patient Affected by a Honeymoon Parkinson's Disease [NA]
A completed clinical trial evaluating the effect of myotensive techniques, with and without auto-reeducation, on forced vital capacity in pa…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Instrumental or Physical-Exercise Rehabilitation of Balance in Parkinson's Disease? (IPER-PD) [NA]
This is a completed clinical trial evaluating instrumental or physical-exercise rehabilitation to improve balance in Parkinson's disease.
-
FDA approval · 2017-10-17FDA Approved: NUPLAZID — Supplemental Application (Acadia Pharmaceuticals Inc.)
FDA approved a supplemental application for NUPLAZID (pimavanserin tartrate) submitted by Acadia Pharmaceuticals.
-
CLINICAL_TRIALS research · 2017-10-17Clinical Trial Update: Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease [Phase 2]
A Phase 2 clinical trial is evaluating lovastatin as a neuroprotective treatment for early-stage Parkinson's disease; the current status is …
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease [NA]
This clinical trial update reports that the study evaluating Osteopathic Manipulative Medicine for pulmonary function and speech in Parkinso…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Study in Parkinson's Disease of Exercise [NA]
A clinical trial evaluating exercise in Parkinson disease has completed, with results posted in October 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders [NA]
A completed clinical study evaluated the combination of cord blood and granulocyte colony-stimulating factor in patients with brain injury a…
-
CLINICAL_TRIALS research · 2017-10-10Clinical Trial Update: Determining Clinical Profile of Parkinson's Disease Among Egyptian Population
This clinical trial aims to determine the clinical profile of Parkinson's disease in the Egyptian population.
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: Pilot Study to Evaluate ActiMyo Measured Activity in Parkinson Disease Patients & Healthy Volunteers [NA]
A pilot study to evaluate ActiMyo measured activity in Parkinson disease patients and healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: COPE-Co-morbidities, Parkinson's Disease and Exercise [NA]
This clinical trial update reports the completion of NCT01361724, a study by Oregon Health and Science University investigating exercise in …
-
CLINICAL_TRIALS withdrawal · 2017-10-06Clinical Trial Update: Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease [Phase 1]
A Phase 1 trial investigating convection-enhanced delivery to study the pathophysiology underlying Parkinson's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease [Phase 3]
A multi-centre UK Phase 3 trial of donepezil in early dementia associated with Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients [Phase 3]
Open-label Phase 3 trial evaluating long-term safety of safinamide in Parkinson's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: Treatment of Executive Dysfunction in Parkinson's Disease [NA]
This clinical trial update reports the completion of a Johns Hopkins University study evaluating treatment for executive dysfunction in Park…
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease [Phase 4]
Phase 4 trial update evaluating pramipexole and bromocriptine on nonmotor symptoms in early Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: A Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease Patient [Phase 2, Phase 3]
A study evaluating the safety and efficacy of human neural stem cells for Parkinson's disease, currently in Phase 2 and Phase 3.